minimizing fatigue and mistakes made by nurses who work night shifts.

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent therapeutic advances in MS!

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

A gastroenterologist explains why treating bowel inflammation alone isn't enough to call inflammatory bowel disease "controlled."

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

Weill Cornell investigator Iliyan D. Iliev, PhD, explains why fluconazole, not nystatin, cleared gut Candida in IBD.

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

A gastroenterologist explains why treating bowel inflammation alone isn't enough to call inflammatory bowel disease "controlled."

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

Weill Cornell investigator Iliyan D. Iliev, PhD, explains why fluconazole, not nystatin, cleared gut Candida in IBD.

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

minimizing fatigue and mistakes made by nurses who work night shifts.

Latest News

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

Residual Asthma Exacerbations on Biologics Vary by Mechanism

Dupilumab's IL-4/IL-13 Blockade Drives Efficacy Edge in EVEREST Guy Brusselle, MD, PhD

Verekitug Reduces Asthma Exacerbations Up to 87%, With Michael Wechsler, MD Michael Wechsler, MD, MSc

8 Pulmonology Headlines You Missed in Q3 2026

8 Pulmonology Headlines You Missed in September 2026

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Latest News

News All Time

Q&A: PERFORM Data Support Triple Therapy in Milder Uncontrolled Asthma John Oppenheimer, MD

Zumilokibart Rapidly Suppresses FeNO in Phase 1b Asthma Data: Mario Castro, MD Mario Castro, MD, MPH

BEAM-302 Base Editing Sustains Protective AAT, With John Hurst, MBBS, PhD John Hurst, MBBS, PhD

Dupilumab Scores on Win-Ratio Analysis in Pediatric Asthma: Sharon Dell, MD Sharon Dell, MD

PDGF Pathway in PAH: Setbacks and Promise, With Olivier Sitbon, MD, PhD Olivier Sitbon, MD, PhD

STAT6 Degraders: Accessible Biologic-Like Asthma Care? With Njira Lugogo, MD Njira Lugogo, MD

AIRCULES: Lunsekimig Benefit Scales With Severity, With Njira Lugogo, MD Njira Lugogo, MD

Verekitug's TSLP Mechanism and VALIANT Trial Results, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Tozorakimab Cuts COPD Exacerbations Across Eosinophil Levels: Frank Sciurba, MD Frank C. Sciurba, MD

Semaglutide Cuts Asthma Attacks by up to 40% in Real-World Study Victoria Johnson

FIBRONEER-ON: Nerandomilast's Durable IPF, PPF Safety, With Wim Wuyts, MD, PhD Wim Wuyts, MD, PhD

Dupilumab Cuts COPD Exacerbations Across Seasons, Smoking Status: Surya Bhatt, MD Surya P. Bhatt, MD

Oral STAT6 Degraders Fill Niche in Asthma Care, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Rademikibart Improves FEV1 in Phase 2 Asthma Exacerbation Trial Victoria Johnson

STAT6 Degradation: A Novel Oral Target for Asthma? Victoria Johnson

FDA Grants Priority Review for Insmed's ARIKAYCE sNDA for MAC Lung Disease

Recommended News For You

Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Dissociative identity disorder: method or fact?

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

Recommended Articles For You

Embryonic Oxygen Consumption and Development: Clinical and Mechanistic Insights

Next-Generation Antibody–Drug Conjugates: Optimizing Payloads, Linkers, and Tumor Selectivity

Long-Term Care After Cancer Remission: Clinical Strategies, Evidence, and Future Directions

Navigating the Complexities of Esophageal Cancer Staging

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.